Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4390695 | 4158325 | F | 1 | 4390695-3 | 20040515 | 20040617 | 20040630 | EXP | 163-20785-04060032 | CELGENE CORPORATION | 72 | YR | M | N | 20040617 | CN | 20040515 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4390695 | 1004990064 | PS | THALOMID | 1 | ORAL | 50 MG, DAILY, ORAL | D | D | 20785 | ||
| 4390695 | 1005008040 | SS | PREDNISONE TAB | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4390695 | 1004990064 | MYELOFIBROSIS |
| 4390695 | 1005008040 | MYELOFIBROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4390695 | DE |
| 4390695 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4390695 | THROMBOSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4390695 | CSM |
| 4390695 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4390695 | 1004990064 | 20040504 | |||
| 4390695 | 1005008040 | 20040504 |